{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:50:39Z","timestamp":1783486239673,"version":"3.55.0"},"reference-count":33,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1488,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1365-2265.2011.04087.x","type":"journal-article","created":{"date-parts":[[2011,4,30]],"date-time":"2011-04-30T12:02:28Z","timestamp":1304164948000},"page":"388-394","source":"Crossref","is-referenced-by-count":57,"title":["Determinants and outcome of amiodarone-associated thyroid dysfunction"],"prefix":"10.1111","volume":"75","author":[{"given":"Sheba","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle C.","family":"Van Gelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans C. P.","family":"Wiesfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"Van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thera P.","family":"Links","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,8,5]]},"reference":[{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators","volume":"342","author":"Roy","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(96)09145-3","article-title":"Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators","volume":"349","author":"Julian","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(96)08171-8","article-title":"Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators","volume":"349","author":"Cairns","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJMct065916","article-title":"Amiodarone for atrial fibrillation","volume":"356","author":"Zimetbaum","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.300.15.1784","article-title":"Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial","volume":"300","author":"Ahmed","year":"2008","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/jc.2008-1907","article-title":"Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome","volume":"94","author":"Yiu","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/er.2003-0033","article-title":"Thyroid hormone action in the heart","volume":"26","author":"Kahaly","year":"2005","journal-title":"Endocrine Reviews"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1210\/jc.87.3.968","article-title":"Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism","volume":"87","author":"Biondi","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/heart.84.4.455","article-title":"Thyroid disease and the heart","volume":"84","author":"Toft","year":"2000","journal-title":"Heart"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/pds.735","article-title":"Amiodarone-induced thyroid dysfunction associated with cumulative dose","volume":"11","author":"Bouvy","year":"2002","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB14|cit14","first-page":"39","article-title":"[Incidence and timing of thyroid dysfunction with long-term amiodarone therapy]","volume":"94","author":"Rouleau","year":"2001","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy","volume":"101","author":"Martino","year":"1984","journal-title":"Annals of Internal Medicine"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9343(91)90187-3","article-title":"Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism","volume":"91","author":"Trip","year":"1991","journal-title":"American Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1365-2265.2008.03268.x","article-title":"Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists","volume":"69","author":"Tanda","year":"2008","journal-title":"Clinical Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2265.2004.02119.x","article-title":"Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association","volume":"61","author":"Bartalena","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/er.22.2.240","article-title":"The effects of amiodarone on the thyroid","volume":"22","author":"Martino","year":"2001","journal-title":"Endocrine Reviews"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.beem.2009.07.001","article-title":"Amiodarone and thyroid","volume":"23","author":"Eskes","year":"2009","journal-title":"Best Practice & Research. Clinical Endocrinology & Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/circ.105.11.1275","article-title":"Successful treatment of amiodarone-induced thyrotoxicosis","volume":"105","author":"Osman","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00002018-200629030-00006","article-title":"Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosis","volume":"29","author":"Uzan","year":"2006","journal-title":"Drug Safety"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB23|cit23","unstructured":"Baskin , H.J. 2006 American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism http:\/\/www.aace.com\/pub\/pdf\/guidelines\/hypo_hyper.pdf"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB24|cit24","first-page":"33","article-title":"[Incidence and predictors of thyroid dysfunction caused by long-term intake of amiodaron]","volume":"77","author":"Serdiuk","year":"2005","journal-title":"Terapevticheskii Arkhiv"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0002-9343(85)90336-5","article-title":"Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function","volume":"78","author":"Borowski","year":"1985","journal-title":"American Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.100.2.149","article-title":"Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease","volume":"100","author":"Thorne","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","article-title":"The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey","volume":"43","author":"Vanderpump","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2009.225","article-title":"Effects of amiodarone therapy on thyroid function","volume":"6","author":"Cohen-Lehman","year":"2010","journal-title":"Nature Reviews. Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB29|cit29","first-page":"269","article-title":"Amiodarone-induced thyroid dysfunction in clinical practice","volume":"10","author":"Ursella","year":"2006","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.0300-0664.2001.01457.x","article-title":"Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography","volume":"56","author":"Eaton","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1080\/02841850701342138","article-title":"Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis","volume":"48","author":"Loy","year":"2007","journal-title":"Acta Radiologica"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/02841850701280791","article-title":"Differentiation between the two types of amiodarone-associated thyrotoxicosis using duplex and amplitude Doppler sonography","volume":"48","author":"Macedo","year":"2007","journal-title":"Acta Radiologica"},{"key":"10.1111\/j.1365-2265.2011.04087.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2011.04087.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2265.2011.04087.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T22:28:30Z","timestamp":1625437710000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2011.04087.x"}},"subtitle":["Thyroid dysfunction and oral amiodarone therapy"],"short-title":[],"issued":{"date-parts":[[2011,8,5]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04087.x","relation":{},"ISSN":["0300-0664"],"issn-type":[{"value":"0300-0664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,5]]}}}